Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no hard rule that bans alcohol entirely while taking Wegovy, but the evidence does flag several reasons to be careful. Semaglutide slows gastric emptying and lowers appetite, which changes how your body handles a drink — and how quickly the effects hit you. These are prescription-only medicines that require a clinical assessment before a prescriber decides whether treatment is appropriate for you. Here is what the clinical guidance and pharmacology actually say, so you can have an informed conversation with your prescriber rather than guessing from forum posts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, established semaglutide's weight-management credentials over 68 weeks, but the mechanism that drives those results is also the one that changes your relationship with a glass of wine. Semaglutide activates GLP-1 receptors in the gut, slowing the rate at which the stomach empties. Food and drink move into the small intestine more slowly, which ordinarily helps you feel full for longer.
That same slowing applies to alcohol. A drink that would normally be absorbed over an hour or so takes longer to leave the stomach and then, when it does move through, may produce a more concentrated peak in the bloodstream. In plain terms, one glass can feel more like one and a half. Most people notice this effect earliest in treatment, or after a dose increase, when gastric slowing is most pronounced.
There is also an appetite angle worth knowing. Many people on Wegovy report that their desire for alcohol decreases alongside food cravings, GLP-1 receptors are active in reward pathways as well as the gut. This is an area of ongoing research rather than a settled clinical instruction, but it is one reason some patients are surprised to find they simply want less. If you would like a thorough overview of how all of this plays out day to day, our page on drinking on Wegovy covers the full picture in one place.
If questions about specific drinks and their effects are useful to you, our page on wine in particular looks at this in more detail.
The NHS medicines guidance for semaglutide does not issue a blanket prohibition on alcohol, but it does flag that alcohol can worsen some of the side effects already associated with treatment. Three risks are worth understanding clearly.
First, nausea. Gastrointestinal discomfort (queasiness, reflux, a heavy unsettled feeling) is the most commonly reported side effect of semaglutide, particularly in the early weeks of each dose step. Alcohol irritates the stomach lining independently. Drinking when your gut is already adjusting to a new dose is a reliable route to a miserable evening.
Second, blood sugar. Semaglutide's glucose-lowering action is modest when used for weight management without diabetes, but alcohol itself can push blood sugar down, especially on an empty stomach. If you have prediabetes or type 2 diabetes alongside your treatment, this combination deserves explicit discussion with your prescriber.
Third, pancreatitis. The MHRA issued a Drug Safety Update in January 2026 reminding prescribers and patients that acute pancreatitis, while infrequent, is a known serious risk with GLP-1 medicines. Alcohol is an independent risk factor for pancreatitis. Severe stomach pain that radiates to the back (with or without vomiting) is a reason to seek urgent medical help, and heavy drinking alongside treatment is not a combination any prescriber would encourage.
For a fuller picture of safe hydration alongside treatment, the considerations around staying well hydrated on Wegovy are also worth reading.
The practical guidance is not "never drink again", it is closer to "think before you pour, and go slowly". A few straightforward adjustments matter more than abstinence for most people.
Eat something before or alongside drinking. The gastric-slowing effect of semaglutide is already at work, but alcohol absorbed into an already-empty stomach is absorbed faster and hits harder. Even a small amount of food helps buffer this. A common pattern our prescribers hear about is someone having a single drink before dinner at a family occasion and feeling the effects of three, a small thing that catches people off guard if they haven't been warned.
Consider your weekly units. The UK Chief Medical Officers' low-risk guidance is 14 units per week maximum, spread across at least three days. On Wegovy, where one drink can behave like more than one, that ceiling becomes more meaningful in practice, not less.
Alcohol also carries roughly 7 calories per gram, close to fat. A treatment that helps reduce calorie intake works less hard if several hundred calories are arriving in liquid form most evenings. This is not a moral point; it is a practical one about whether the medicine can do what you are taking it for.
If your question is more specifically about beer rather than alcohol in general, the considerations around carbonated drinks and Wegovy add an extra layer. And if you are thinking about your treatment more broadly, the Wegovy overview page covers the full clinical picture.
Most people on Wegovy who drink moderately and sensibly will not come to harm. But a few situations warrant a conversation with your prescriber before your next scheduled review rather than waiting.
Contact your clinical team if: you notice that alcohol is making nausea or vomiting significantly worse; you experience stomach pain that does not settle; you have diabetes or prediabetes and feel shaky or unwell after drinking; or you find you are struggling to cut back on alcohol now that food cravings have reduced and drinking has become a substitute. That last point is more common than it sounds and is worth raising early.
Pregnancy is a separate and firm boundary: semaglutide is not recommended during pregnancy or breastfeeding, or for those actively trying to conceive. Our page on Wegovy and pregnancy covers this in full.
You can report any suspected side effect, including those you think might be linked to alcohol use alongside treatment, via the MHRA's Yellow Card scheme, it helps build the safety picture for everyone.
If you are weighing up whether treatment is right for you, or you have questions about how your lifestyle fits around it, check your eligibility with a free consultation and a prescriber will review your situation personally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.